Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yardena Samuels

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Pigment Cell & Melanoma Research|August 25, 2015
The functional relevance of somatic synonymous mutations in melanoma and other cancersValer Gotea, Jared J Gartner, Nouar Qutob, et al.
Annual Review of Genomics and Human Genetics|July 24, 2013
The genetics of melanoma: recent advancesVictoria K Hill, Jared J Gartner, Yardena Samuels, et al.
Nature Cancer|July 6, 2023
The landscape of T cell antigens for cancer immunotherapyAviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Molecular and Cellular Biology|January 20, 2004
ASPP1 and ASPP2: common activators of p53 family membersDaniele Bergamaschi, Yardena Samuels, Boquan Jin, et al.
Iscience|October 28, 2022
NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membraneOren Yakovian, Julia Sajman, Michal Alon, et al.
Bioinformatics (Oxford, England)|April 27, 2013
Shimmer: detection of genetic alterations in tumors using next-generation sequence dataNancy F Hansen, Jared J Gartner, Lan Mei, et al.
Cancer Biology & Therapy|April 29, 2010
Novel somatic mutations in heterotrimeric G proteins in melanomaL Isabel Cárdenas-Navia, Pedro Cruz, Jimmy C Lin, et al.
Cancer Research|December 23, 2020
MEK Inhibition Reverses Aberrant Signaling in Melanoma Cells through Reorganization of NRas and BRAF in Self NanoclustersOren Yakovian, Julia Sajman, Rand Arafeh, et al.
Neurology. Genetics|April 29, 2016
Parkinson disease (PARK) genes are somatically mutated in cutaneous melanomaRivka Inzelberg, Yardena Samuels, Esther Azizi, et al.
Scientific Reports|March 13, 2019
Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cellsRand Arafeh, Karen Flores, Alona Keren-Paz, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Pigment Cell & Melanoma Research|August 25, 2015
The functional relevance of somatic synonymous mutations in melanoma and other cancersValer Gotea, Jared J Gartner, Nouar Qutob, et al.
Annual Review of Genomics and Human Genetics|July 24, 2013
The genetics of melanoma: recent advancesVictoria K Hill, Jared J Gartner, Yardena Samuels, et al.
Nature Cancer|July 6, 2023
The landscape of T cell antigens for cancer immunotherapyAviyah Peri, Nadja Salomon, Yochai Wolf, et al.
Molecular and Cellular Biology|January 20, 2004
ASPP1 and ASPP2: common activators of p53 family membersDaniele Bergamaschi, Yardena Samuels, Boquan Jin, et al.
Iscience|October 28, 2022
NRas activity is regulated by dynamic interactions with nanoscale signaling clusters at the plasma membraneOren Yakovian, Julia Sajman, Michal Alon, et al.
Bioinformatics (Oxford, England)|April 27, 2013
Shimmer: detection of genetic alterations in tumors using next-generation sequence dataNancy F Hansen, Jared J Gartner, Lan Mei, et al.
Cancer Biology & Therapy|April 29, 2010
Novel somatic mutations in heterotrimeric G proteins in melanomaL Isabel Cárdenas-Navia, Pedro Cruz, Jimmy C Lin, et al.
Cancer Research|December 23, 2020
MEK Inhibition Reverses Aberrant Signaling in Melanoma Cells through Reorganization of NRas and BRAF in Self NanoclustersOren Yakovian, Julia Sajman, Rand Arafeh, et al.
Neurology. Genetics|April 29, 2016
Parkinson disease (PARK) genes are somatically mutated in cutaneous melanomaRivka Inzelberg, Yardena Samuels, Esther Azizi, et al.
Scientific Reports|March 13, 2019
Author Correction: Combined inhibition of MEK and nuclear ERK translocation has synergistic antitumor activity in melanoma cellsRand Arafeh, Karen Flores, Alona Keren-Paz, et al.
Pageof 11